Cefuroxime
CEFUROXIME FOR INJECTION, USP
Approved
Approval ID
19902965-d2d6-433f-982d-0095014df4e8
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 27, 2018
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefuroxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9568
Application NumberANDA065048
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 27, 2018
FDA Product Classification
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 750 mg in 1 1
Code: R8A7M9MY61
Classification: ACTIM
Cefuroxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9567
Application NumberANDA065048
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 27, 2018
FDA Product Classification
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 1.5 g in 1 1
Code: R8A7M9MY61
Classification: ACTIM